Qmenta Care Platform Family
Mint Labs, Inc., d/b/a. QMENTA • Radiology • 06/16/2021
Device Purpose
The QMENTA Care Platform Family is a software system designed to streamline medical image management and analysis by providing a platform for DICOM image archiving, retrieval, and network accessibility. Its methodology centers on a dual-component architecture featuring a storage/archiving server and a workflow server that integrates legally marketed clinical applications, enabling configurable image processing and report generation to support physician diagnoses.
Summary
The QMENTA Care Platform Family is a software-based medical imaging system designed to enhance clinical workflows by managing and processing radiological images. It operates by receiving DICOM images from various modalities such as CT, MR, and PET/CT, along with textual reports, organizing this data, and making it accessible over a network through web and custom interfaces. The platform comprises two main components: a storage/archiving server for retrieving and managing image data from PACS or file storage, and a workflow server that enables the integration and execution of various legally marketed clinical applications for specific image analysis tasks. The system allows for the computation of these integrated applications, generating outputs that can include image overlays, numerical reports, or other derived results, which can then be saved as DICOM files for viewing on standard imaging workstations. Its methodology involves configurable dataflow management, a protocol adherence engine to ensure studies meet application requirements, and a software development kit for integrating third-party tools. The QMENTA Care Platform Family is intended to assist qualified physicians in their diagnostic processes, supporting their expertise and established protocols without mandating reliance on specific image maps or quantifications produced by the system; its performance and adherence to design specifications were confirmed through comprehensive software validation, risk management, and usability testing.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the QMENTA Care Platform Family's 'Protocol Adherence Engine' specifically validate DICOM image parameters for diverse clinical applications, and what is the range of its configurability?; What are the specific performance metrics (e.g., processing speed, data throughput) of the platform when handling large datasets from multiple modalities simultaneously, particularly in a cloud-deployed environment?; Can the QMENTA Software Development Kit (SDK) be utilized to integrate custom-developed, non-marketed research algorithms, and what are the validation requirements for such integrations within the platform?; How does the system ensure data integrity and security, particularly for patient data, during transfer, storage, and processing, especially when utilizing cloud resources and third-party applications?; What is the typical learning curve and training requirement for physicians and IT staff to effectively utilize and manage the QMENTA Care Platform Family, including the integration of new clinical applications?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class B (software safety classification); Authorized before §524B enforcement
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, SaaSBOM, OBOM detected in AI-generated device summary.
• This device was authorized before §524B took effect. Cybersecurity evidence requirements were less prescriptive at the time.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, HBOM, CBOM, VDR/VEX. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly